MoU between India and UK on Cancer Research

MoU between India and UK on Cancer Research

Agency News

New Delhi, Mar 7 : The Union Cabinet chaired by Prime Minister Narendra Modi on Thursday approved the Memorandum of Understanding between India and the UK on Cancer Research Initiative which will provide funding to develop new research alliances and undertake impactful research to enable significant progress against cancer outcomes.

The MoU was signed on 14 November 2018, said Union Minister Arun Jaitley, briefing reporters after the meeting, chaired by Prime Minister Narendra Modi.

The India-UK Cancer Research Initiative will identify a core set of research challenges that address issues of affordability, prevention and care of cancer by bringing together leading Indian and UK experts across clinical research, demographic research, new technologies and physical sciences.

Over 5 years, the total research funding for the Initiative will be Rs 90 crore. Cancer Research UK (CRUK)'s share for such funding will be Rs 45 crores. DBT will match such funding by Rs 45 crore. The matching funds will be as per prevailing rates at the beginning of financial year.

Despite the surge in technological, biomedical, clinical, and pharmaceutical innovations aimed at improving cancer outcomes, the overburdened healthcare systems across the globe remain ill equipped to meet the massive burden of escalating cancer care costs.

The India-UK Cancer Research Initiative sets forth a roadmap for catalysing collaborations that align the best researchers, scientists, healthcare organisations and institutions to a multi-disciplinary research platform leading to high value, low cost outcomes for cancer care.

Through this initiative the number of positions for doctoral-level, post-doctoral level researchers and early career scientists are expected to grow. They will not only be trained in cutting technology but will also be trained in essential leadership and project management skills which would help them in securing tenure-track research positions in academia or in related bio-pharma industry.

The India-UK Cancer Research Initiative is a collaborative 5-year bilateral research initiative by the Department of Biotechnology(DBT), Ministry of Science & Technology, India and CRUK that will focus on affordable approaches to cancer.

Both CRUK and DBT will invest Rs 45 crore each in this 5-year pilot, and seek further investment from other potential funding partners. This is a follow up of the joint statement issued by the two Prime Ministers during the visit of Prime Minister Narendra Modi to UK on April 18, 2018, which stated that ''as thriving democracies, we share a desire to work closely together and with all who share our objective to support a rules-based international order that upholds agreed international norms, global peace and stability. Together the UK and India are a force for good in an uncertain world.

''We are sharing our experience and knowledge to tackle global challenges. India's Department of Biotechnology (DBT) and Cancer Research UK propose to launch a Rs 90 crore bilateral research initiative which will focus on low cost approaches to cancer treatment." (UNI)